| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Gastrointestinal cancer
Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection
Sujin Park, Sangjoon Choi, Yoon Ah Cho, Dong Hyun Sinn, Jong Man Kim, Cheol-Keun Park, Sang Yun Ha
Cancer Res Treat. 2020;52(4):1145-1152.   Published online April 28, 2020    DOI: https://doi.org/10.4143/crt.2020.208
                              Supplementary      
Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma
Miao Xue, Yanqin Wu, Wenzhe Fan, Jian Guo, Jialiang Wei, Hongyu Wang, Jizhou Tan, Yu Wang, Wang Yao, Yue Zhao, Jiaping Li
Cancer Res Treat. 2020;52(3):925-937.   Published online March 30, 2020    DOI: https://doi.org/10.4143/crt.2019.533
                                 Cited By 1
Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
Xiaoting Song, Ailu Wu, Zhixiao Ding, Shixiong Liang, Chunyan Zhang
Cancer Res Treat. 2020;52(3):789-797.   Published online March 5, 2020    DOI: https://doi.org/10.4143/crt.2019.749
                                 Cited By 1
Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma
Li Sun, Lin Zhang, Jun Chen, Chaoqun Li, Hongqin Sun, Jiangrong Wang, Hong Xiao
Cancer Res Treat. 2020;52(2):604-621.   Published online December 27, 2019    DOI: https://doi.org/10.4143/crt.2019.444
                              Supplementary         Cited By 2
Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma
Guo-Pei Zhang, Xiao Yue, Shao-Qiang Li
Cancer Res Treat. 2020;52(1):10-23.   Published online April 26, 2019    DOI: https://doi.org/10.4143/crt.2019.145
                                 Cited By 1
Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05)
Sun Hyun Bae, Hee Chul Park, Won Sup Yoon, Sang Min Yoon, In-Hye Jung, Ik Jae Lee, Jun Won Kim, Jinsil Seong, Tae Hyun Kim, Taek-Keun Nam, Youngmin Choi, Sun Young Lee, Hong Seok Jang, Dong Soo Lee, Jin Hee Kim
Cancer Res Treat. 2019;51(4):1589-1599.   Published online April 10, 2019    DOI: https://doi.org/10.4143/crt.2018.687
                              Supplementary         Cited By 3
Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy
Yifei Wang, Kaiyu Sun, Jingxian Shen, Bin Li, Ming Kuang, Qinghua Cao, Sui Peng
Cancer Res Treat. 2019;51(4):1464-1478.   Published online March 11, 2019    DOI: https://doi.org/10.4143/crt.2018.657
                              Supplementary         Cited By 8
Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study
Sanghyuk Im, Eun Sun Jang, Ju Hyun Lee, Chung Seop Lee, Beom Hee Kim, Jung Wha Chung, Jin-Wook Kim, Sook-Hyang Jeong
Cancer Res Treat. 2019;51(4):1357-1369.   Published online February 12, 2019    DOI: https://doi.org/10.4143/crt.2018.430
                              Supplementary      
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo
Cancer Res Treat. 2019;51(2):510-518.   Published online June 13, 2018    DOI: https://doi.org/10.4143/crt.2018.226
                              Supplementary         Cited By 11
Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
Zhang Zhaohui, Shen Shunli, Chen Bin, Li Shaoqiang, Hua Yunpeng, Kuang Ming, Liang Lijian, Peng Bao Gang
Cancer Res Treat. 2019;51(1):65-72.   Published online February 26, 2018    DOI: https://doi.org/10.4143/crt.2018.038
                                 Cited By 3
Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy
Sang Chul Lee, Kee-Hwan Kim, Ok-Hee Kim, Sang Kuon Lee, Ha-Eun Hong, Byung Jo Choi, Wonjun Jeong, Say-June Kim
Cancer Res Treat. 2018;50(3):1023-1038.   Published online November 9, 2017    DOI: https://doi.org/10.4143/crt.2017.085
                                 Cited By 3
Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function
Yeonjung Ha, Daejung Kim, Seungbong Han, Young Eun Chon, Yun Bin Lee, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
Cancer Res Treat. 2018;50(3):843-851.   Published online September 4, 2017    DOI: https://doi.org/10.4143/crt.2017.232
                              Supplementary         Cited By 11
Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma
Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong
Cancer Res Treat. 2018;50(3):646-657.   Published online July 17, 2017    DOI: https://doi.org/10.4143/crt.2016.550
                              Supplementary         Cited By 3
Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su
Cancer Res Treat. 2018;50(2):530-537.   Published online June 1, 2017    DOI: https://doi.org/10.4143/crt.2017.156
                              Supplementary         Cited By 7
Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
Jeong-Ju Yoo, Goh Eun Chung, Jeong-Hoon Lee, Joon Yeul Nam, Young Chang, Jeong Min Lee, Dong Ho Lee, Hwi Young Kim, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Seoul Liver Group
Cancer Res Treat. 2018;50(2):366-373.   Published online May 15, 2017    DOI: https://doi.org/10.4143/crt.2017.126
                                 Cited By 4
Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kim, Moon Soo Lee, Moo-Jun Baek
Cancer Res Treat. 2017;49(1):246-254.   Published online July 7, 2016    DOI: https://doi.org/10.4143/crt.2016.066
                                 Cited By 62
Studying the Effect of Downregulating Autophagy-Related Gene LC3 on TLR3 Apoptotic Pathway Mediated by dsRNA in Hepatocellular Carcinoma Cells
Guilan Wang, Maona Zhang, Yunlong Li, Jiaming Zhou, Li Chen
Cancer Res Treat. 2017;49(1):230-245.   Published online June 13, 2016    DOI: https://doi.org/10.4143/crt.2015.506
                                 Cited By 2
Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07)
Hyejung Cha, Hee Chul Park, Jeong Il Yu, Tae Hyun Kim, Taek-Keun Nam, Sang Min Yoon, Won Sup Yoon, Jun Won Kim, Mi Sook Kim, Hong Seok Jang, Youngmin Choi, Jin Hee Kim, Chul Seung Kay, Inkyung Jung, Jinsil Seong
Cancer Res Treat. 2017;49(1):61-69.   Published online June 13, 2016    DOI: https://doi.org/10.4143/crt.2016.097
                                 Cited By 6
Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method
Seesai Yeesoonsang, Surichai Bilheem, Edward McNeil, Sophon Iamsirithaworn, Chuleeporn Jiraphongsa, Hutcha Sriplung
Cancer Res Treat. 2017;49(1):54-60.   Published online May 18, 2016    DOI: https://doi.org/10.4143/crt.2016.045
                                 Cited By 2
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
Do Young Kim, Hye Jin Kim, Kwang-Hyub Han, Sang Young Han, Jeong Heo, Hyun Young Woo, Soon Ho Um, Yeul Hong Kim, Young Oh Kweon, Ho Yeong Lim, Jung Hwan Yoon, Wan Sik Lee, Byung Seok Lee, Han Chu Lee, Baek-Yeol Ryoo, Seung Kew Yoon
Cancer Res Treat. 2016;48(4):1243-1252.   Published online February 24, 2016    DOI: https://doi.org/10.4143/crt.2015.278
                                 Cited By 10
A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer
Soo Jeong Nam, Hyun Yang Yeo, Hee Jin Chang, Bo Hyun Kim, Eun Kyung Hong, Joong-Won Park
Cancer Res Treat. 2016;48(4):1229-1242.   Published online March 30, 2016    DOI: https://doi.org/10.4143/crt.2015.500
                                 Cited By 9
The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
Sang Yun Ha, Jeong Hoon Kim, Jung Wook Yang, Jimin Kim, Binnari Kim, Cheol-Keun Park
Cancer Res Treat. 2016;48(3):1065-1073.   Published online October 16, 2015    DOI: https://doi.org/10.4143/crt.2015.302
                                 Cited By 7
Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Seung Woon Paik
Cancer Res Treat. 2016;48(2):574-582.   Published online July 17, 2015    DOI: https://doi.org/10.4143/crt.2015.076
                              Supplementary         Cited By 7
Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Hong In Yoon, Ki Jun Song, Ik Jae Lee, Do Young Kim, Kwang-Hyub Han, Jinsil Seong
Cancer Res Treat. 2016;48(1):190-197.   Published online March 5, 2015    DOI: https://doi.org/10.4143/crt.2014.276
                                 Cited By 9
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy
Sang Yun Ha, Misun Choi, Taebum Lee, Cheol-Keun Park
Cancer Res Treat. 2016;48(1):180-189.   Published online March 18, 2015    DOI: https://doi.org/10.4143/crt.2014.321
                              Supplementary         Cited By 2
ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
Hye Won Hwang, Sang Yun Ha, Heejin Bang, Cheol-Keun Park
Cancer Res Treat. 2015;47(4):853-861.   Published online February 16, 2015    DOI: https://doi.org/10.4143/crt.2014.177
                                 Cited By 23
Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma
Heejin Bang, Sang Yun Ha, Soo Hyun Hwang, Cheol-Keun Park
Cancer Res Treat. 2015;47(4):844-852.   Published online February 13, 2015    DOI: https://doi.org/10.4143/crt.2014.124
                                 Cited By 20
Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
Dongryul Oh, Sung Wook Shin, Hee Chul Park, Sung Ki Cho, Do Hoon Lim, Seung Woon Paik
Cancer Res Treat. 2015;47(2):251-258.   Published online October 27, 2014    DOI: https://doi.org/10.4143/crt.2014.011
                                 Cited By 7
Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
Tae Hyun Kim, Joong-Won Park, Yeon-Joo Kim, Bo Hyun Kim, Sang Myung Woo, Sung Ho Moon, Sang Soo Kim, Young-Hwan Koh, Woo Jin Lee, Sang Jae Park, Joo-Young Kim, Dae Yong Kim, Chang-Min Kim
Cancer Res Treat. 2015;47(1):34-45.   Published online September 11, 2014    DOI: https://doi.org/10.4143/crt.2013.218
                                 Cited By 29
Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma
Jeong Il Yu, Sang Min Yoon, Hee Chul Park, Jong Hoon Kim, Tae Hyun Kim, Joong-Won Park, Jinsil Seong, Ik Jae Lee, Hong Seok Jang, Chul Seung Kay, Chul Yong Kim, Eui Kyu Chie, Jin Hee Kim, Mi-Sook Kim, Young Min Choi
Cancer Res Treat. 2014;46(4):348-357.   Published online July 16, 2014    DOI: https://doi.org/10.4143/crt.2013.142
                                 Cited By 11
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community